Genopole® is France’s leading biotech- and biotherapy-dedicated science and business park.
A pioneering, sector-leading location.
- 21 academic research laboratories, including the CEA Genomics Institute (which houses the French national sequencing and genotyping facilities).
- 73 biotech companies
- 18 shared-access technology platforms and technical facilities
- 91,929 m2 of real estate
- 2,107 staff on the biopark
Dynamism, synergy and innovation
The Evry-Corbeil Genopole®’s success is largely based on what is a rare feature in France: public- and private-sector research units, university teaching and hi-tech life science businesses at a single location.
Genopole®’s strategic mission is to transform scientific progress into innovative treatments for human healthcare.
While remaining faithful to its founding objective, Genopole® has shaped its own identity and is now France’s benchmark biopark.